Long-term therapy. Face may exhibit atrophic changes after prolonged treatment. Avoid contact w/ eyes. Risk of rebound relapses, development of tolerance & generalized pustular psoriasis for local & systemic toxicity (carefully monitor patient when used in psoriasis). Childn & infants. Pregnancy.
Skin atrophy especially w/ occlusion or in skin folds, hypercorticism.